The prevalence of atrial fibrillation (AFib) in β-thalassemia major (β-TM) patients has increased in the last few years, reaching up to 33.0%. Several factors may drive this value to even more in the next few years. We summarized the main challenges in the management and therapy of AFib in this very specific group of patients.

Atrial fibrillation in β-thalassemia Major Patients: Diagnosis, Management and Therapeutic Options

Barbero U;Fornari F;Gaglioti CM;Anselmino M;Piga A.
Last
2018-01-01

Abstract

The prevalence of atrial fibrillation (AFib) in β-thalassemia major (β-TM) patients has increased in the last few years, reaching up to 33.0%. Several factors may drive this value to even more in the next few years. We summarized the main challenges in the management and therapy of AFib in this very specific group of patients.
2018
Oct
1
5
Arrhythmia; atrial fibrillation (AFib); iron overload; β-thalassemia (β-thal); Hematology; Genetics (clinical); Clinical Biochemistry; Biochemistry (medical)
Barbero U, Fornari F, Guarguagli S, Gaglioti CM, Longo F, Doronzo B, Anselmino M, Piga A.
File in questo prodotto:
File Dimensione Formato  
Barbero LHEM-42-2-2018-0070-REVISED-3rd version_UB.docx

Accesso riservato

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 34.8 kB
Formato Microsoft Word XML
34.8 kB Microsoft Word XML   Visualizza/Apri   Richiedi una copia
Barbero LHEM-42-2-2018-0070-REVISED-3rd version_UB.pdf

Accesso aperto

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 51.71 kB
Formato Adobe PDF
51.71 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1678177
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 15
social impact